Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Validate Your Expertise in PK/PD NCA Analysis Through Certara Professional Certification

In the ongoing commitment to education and coinciding with the launch of Phoenix 8.1, Certara has introduced a new certification program available through Certara University. The new online accreditation program validates the scientists’ PK/PD data analysis skills using Certara software such as Phoenix WinNonlin and expands their professional reach. I caught up with Ana Henry, […]

Author(s): Maria Saluta
Solution: Clinical Pharmacology Strategy, Model-informed Drug Development, PK/PD Modeling & Simulation
Therapeutic Area: Cardiovascular, Central Nervous System, Dermatology, Endocrinology, Infectious Disease, Oncology/Hematology, Pediatrics, Rare/Orphan Disease
More Info

Overcoming Pitfalls and Challenges with Software Validation

As a quality consultant and quality system subject matter expert in the Life Sciences Industry for over 25 years, I have worked for many pharmaceutical companies both large and small and as a consultant with many clients in the pharmaceutical, biotech, and medical device industries. These clients possess a range of experience in software validation—from […]

Author(s): Noreen Muscat
Solution: Clinical Pharmacology Strategy, Clinical Transparency & Disclosure, Drug Development & Regulatory Strategy, Model-informed Drug Development, PK/PD Modeling & Simulation
Therapeutic Area: Cardiovascular, Central Nervous System, Dermatology, Endocrinology, Infectious Disease, Oncology/Hematology, Pediatrics, Rare/Orphan Disease
More Info

Real Patients & Their Virtual Twins: A New Paradigm for Personalized Drug Safety Assessment

In this webinar, Sebastian Polak, Nikunj Patel, and Mark Holbrook introduced the Cardiac Safety Simulator (CSS) platform and explained how they developed a QSTS model for citalopram to serve as a “virtual twin” and help predict the likely occurrence of cardiotoxic events in real patients under different clinical conditions.

Speaker(s): Mark Holbrook, Nikunj Patel, Sebastian Polak
Solution: PBPK Modeling & Simulation
Therapeutic Area: Central Nervous System
More Info

Validation Made Easier! Tips and Guidance from the Experts

In this webinar, Noreen Muscat from QACV Consulting discussed common pitfalls in validation and how to avoid them, and Allan Michaels, Sr. Project Manager of Phoenix Technology Services, shared how the latest Validation Suite for Phoenix WinNonlin expedites validation and provides robust reporting.

Speaker(s): Noreen Muscat, Allan Michaels
Solution: PK/PD Modeling & Simulation
More Info

Accomplish More with Phoenix

Phoenix 8.1, the newest version of Certara’s innovative PK/PD modeling and simulation software used globally by researchers and drug developers in pharma, academia, and regulatory agencies, will be available on June 15, 2018. Major enhancements were introduced in the Phoenix workbench last year. And as an ongoing commitment to support compliance and efficiency, many features […]

Author(s): Venkateswari Muthukrishnan
Solution: Clinical Pharmacology Strategy, Model-informed Drug Development, PK/PD Modeling & Simulation
Therapeutic Area: Cardiovascular, Central Nervous System, Dermatology, Endocrinology, Infectious Disease, Oncology/Hematology, Pediatrics, Rare/Orphan Disease
More Info

Accomplish More with Phoenix—New Phoenix 8.1 Release in June 2018!

As the gold standard for PK/PD software, our upcoming Phoenix 8.1 release delivers new capabilities to automate processes, reduce errors, and save you time. Dr. Nathan Teuscher, VP of Pharmacometric Consulting, Venkateswari Muthukrishnan, Phoenix WinNonlin Product Manager, and Ana Henry, Executive Director of Training, shared our latest innovations in WinNonlin and NLME and conducted a live demo.

Speaker(s): Nathan Teuscher, Venkateswari Muthukrishnan, Ana Henry
Solution: PK/PD Modeling & Simulation
More Info
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog